Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  British Journal of Rheumatology

• Publication date

  1990-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/RHEUMATOLOGY/29.1.58PMID 2407306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis

  2004cited by this paper
• Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

  1989cited by this paper
• Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

  1989cited by this paper
• MS: a CNS and systemic autoimmune disease.

  1989cited by this paper
• Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.

  1989cited by this paper
• Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

  1989cited by this paper
• Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

  1989cited by this paper
• Increased expression of p150,95 and CR3 leukocyte adhesion molecules by mononuclear phagocytes in rheumatoid synovial membranes. Comparison with osteoarthritic and normal synovial membranes.

  1989cited by this paper
• T cell receptor genes and disease susceptibility.

  1989cited by this paper
• Tumour necrosis factor in synovial exudates.

  1988cited by this paper
• Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

  1988cited by this paper
• Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma.

  1988cited by this paper
• Molecular genetics of the HLA-D region component of inherited susceptibility to rheumatoid arthritis.

  1988cited by this paper
• Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.

  1988cited by this paper
• Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice

  1988cited by this paper
• Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

  1988cited by this paper
• Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.

  1988cited by this paper
• Interleukin 6 is involved in interleukin 1‐induced activities

  1988cited by this paper
• Synovial lymphocyte responses to microbial antigens differentiate the arthritis of enteric reactive arthritis from the arthritis of inflammatory bowel disease.

  1988cited by this paper
• B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

  1988cited by this paper
• Adhesive protein receptors on hematopoietic cells.

  1988cited by this paper
• Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody.

  1988cited by this paper
• The preferential accumulation of helper‐inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion

  1988cited by this paper
• Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

  1988cited by this paper
• The progression of the inflammation in established collagen‐induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities

  1988cited by this paper
• Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

  1988cited by this paper
• Clonal dominance among T-lymphocyte infiltrates in arthritis.

  1988cited by this paper
• B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

  1988cited by this paper
• Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

  1988cited by this paper
• Cellular immunology of HIV-infection.

  1988cited by this paper
• Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

  1988cited by this paper
• Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

  1988cited by this paper
• Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

  1988cited by this paper
• Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

  1988cited by this paper
• Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

  1988cited by this paper
• Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis.

  1988cited by this paper
• Heterogeneity of T cell receptor idiotypes in rheumatoid arthritis.

  1988cited by this paper
• Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins.

  1988cited by this paper
• Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

  1988cited by this paper
• Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction.

  1988cited by this paper
• T-cell vaccination.

  1988cited by this paper
• Response to monoclonal CD7 antibody in rheumatoid arthritis.

  1988cited by this paper
• A Minority of Patients with Rheumatoid Arthritis Show a Dominant Rearrangement of T‐Cell Receptor β Chain Genes in Synovial Lymphocytes

  1987cited by this paper
• Secretory products of macrophages.

  1987cited by this paper
• Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis.

  1987cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor.

  1987cited by this paper
• THE ASSOCIATION OF DNA VARIANTS AT OR NEAR THE IgH LOCUS WITH RHEUMATOID ARTHRITIS

  1987cited by this paper
• Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint.

  1987cited by this paper
• Immunoregulatory Lymphokines in Rheumatoid Joints

  1987cited by this paper
• Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.

  1987cited by this paper
• Production of hybridoma growth factor by human monocytes

  1987cited by this paper
• Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure.

  1987cited by this paper
• The autologous mixed lymphocyte reaction and dendritic cells.

  1987cited by this paper
• Analyses of HLA linkage in white families with multiple cases of seropositive rheumatoid arthritis.

  1987cited by this paper
• Monoclonal anti-CD4 in arthritis.

  1987cited by this paper
• Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood.

  1986cited by this paper
• Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

  1986cited by this paper
• Heterogeneity of accessory cells interacting with T-helper clones.

  1986cited by this paper
• Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation.

  1986cited by this paper
• Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.

  1986cited by this paper
• T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage.

  1986cited by this paper
• Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma-interferon.

  1986cited by this paper
• Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

  1986cited by this paper
• Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers.

  1986cited by this paper
• Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.

  1986cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Interleukin 1: an immunological perspective.

  1985cited by this paper
• Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

  1985cited by this paper
• The isolation and characterization of the human helper inducer T cell subset.

  1985cited by this paper
• The isolation and characterization of the human suppressor inducer T cell subset.

  1985cited by this paper
• Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

  1985cited by this paper
• Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin.

  1985cited by this paper
• Lymphocyte Activation in Rheumatoid Arthritis Synovial Fluid in Vivo

  1985cited by this paper
• Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4

  1985cited by this paper
• Proliferating Cells in the Synovial Fluid in Rheumatic Disease

  1985cited by this paper
• Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.

  1985cited by this paper
• Lymphocytes from the site of disease but not blood lymphocytes indicate the cause of arthritis.

  1985cited by this paper
• B Cell Differentiation Factor in Synovial Fluid of Patients with Rheumatoid Arthritis

  1984cited by this paper
• Interleukin-1 and the pathogenesis of the acute-phase response.

  1984cited by this paper
• Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

  1984cited by this paper
• Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids.

  1984cited by this paper
• Increased DNA and/or RNA content of synovial fluid cells in rheumatoid arthritis: a flow-cytometry study.

  1984cited by this paper
• The pyrogenic and mitogenic actions of interleukin-1 are related

  1983cited by this paper
• Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF.

  1983cited by this paper
• An interleukin 1 like factor stimulates bone resorption in vitro

  1983cited by this paper
• Isolation of an interleukin-1-like factor from human joint effusions.

  1983cited by this paper
• Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.

  1983cited by this paper
• The demonstration of an interleukin-2 like activity in the synovial fluids of rheumatoid arthritis patients.

  1983cited by this paper
• Multiple abnormalities in immunoregulatory function of synovial compartment T cells in patients with rheumatoid arthritis

  1982cited by this paper
• An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.

  1982cited by this paper
• The specificity of synovial mononuclear cell responses to microbiological antigens in Reiter's syndrome.

  1982cited by this paper
• RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION

  1981cited by this paper
• Cell-mediated immune responses of synovial mononuclear cells in Reiter's syndrome against ureaplasmal and chlamydial antigens.

  1980cited by this paper
• Lack of suppressor cell activity in rheumatoid synovial lymphocytes.

  1979cited by this paper
• Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

  1978cited by this paper
• Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

  1978cited by this paper
• Antigen and Unspecific Mitogen Stimulation of Lymphocytes Eluted from Rheumatoid Inflammatory Tissue

  1976cited by this paper

• Importance of integrin receptors in the field of pharmaceutical & medical science

  2013cites this paper
• An evaluation of the anti-inflammatory activity and mechanism of action of three novel auranofin derivatives

  2009cites this paper
• ROLE OF ADHESION MECHANISMS IN THE PATHOGENESIS OF CHRONIC SYNOVmS

  2005cites this paper
• Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-α4 antibody in adjuvant arthritis

  2004cites this paper
• Patient reporting of adverse drug reactions: useful information for pain management?

  2003cites this paper
• Biologics in the treatment of rheumatoid arthritis: mechanisms of action.

  2001cites this paper
• Erratum to “Establishment of a Consistent L929 Bioassay System for TNF-α Quantitation to Evaluate the Effect of Lipopolysaccharide, Phytomitogens and Cytodifferentiation Agents on Cytotoxicity of TNF-α Secreted by Adherent Human Mononuclear Cells”

  2001cites this paper
• Rationale and risks of novel immunomodulatory therapies in rheumatoid arthritis.

  1999cites this paper
• An overview of immunomodulatory intervention in rheumatoid arthritis.

  1999cites this paper
• Targeted medication review: patients in the community with chronic pain

  1998cites this paper
• Potential roles of the pharmacist in chronic pain management: a multidisciplinary perspective in primary care

  1998cites this paper
• HLA-DR expression in synovial membrane of juvenile rheumatoid arthritis (JRA) versus osteoarthritis (OA).

  1997cites this paper
• Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.

  1997cites this paper
• The Michael Mason Prize Essay 1996. Role of adhesion mechanisms in the pathogenesis of chronic synovitis.

  1996cites this paper
• Application of murine T-T hybridoma cells to in vitro potency assay of human synthetic peptide vaccines.

  1996cites this paper
• The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients

  1995cites this paper
• Biologic interventions in rheumatoid arthritis.

  1995cites this paper
• Investigation of an adjuvant-enhanced model of murine arthritis and its therapeutic application

  1994cites this paper
• CGP 47969A: effect on collagen induced arthritis in DBA/1 mice.

  1994cites this paper
• Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine.

  1994cites this paper
• Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant‐enhanced arthritis in MRL‐lpr mice

  1994cites this paper
• Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.

  1994cites this paper
• Anticorps monoclonaux et polyarthrite rhumatoïde

  1993cites this paper
• Remission of severe rheumatoid arthritis following liver transplantation.

  1993cites this paper
• Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response.

  1993cites this paper
• Macrophages, synovial tissue and rheumatoid arthritis.

  1993cites this paper
• Chimaeric anti‐CD4 monoclonal antibody cross‐linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes

  1993cites this paper
• Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications.

  1993cites this paper
• [Monoclonal antibodies and rheumatoid polyarthritis].

  1993cites this paper
• [Present and future therapeutic strategies in rheumatoid arthritis].

  1993cites this paper
• Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

  1993cites this paper
• The emerging role of biologics in rheumatic disease.

  1992cites this paper
• Immunotherapy of rheumatoid arthritis.

  1992cites this paper
• Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis.

  1992cites this paper
• Activation of HLA‐DR and Interleukin‐6 Gene Transcription in Resting T Cells via the CD2 Molecule: Relevance to Chronic Immune‐Mediated Inflammation

  1992cites this paper
• Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination.

  1992cites this paper
• Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis.

  1992cites this paper
• [Monoclonal antibodies in the treatment of rheumatoid arthritis].

  1992cites this paper
• Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls

  1992cites this paper
• Objectives and outcome of running an early inflammatory arthritis clinic.

  1992cites this paper
• The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis.

  1992cites this paper
• Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone

  1992cites this paper
• Intervention with immunomodulatory agents: T cell vaccination

  1992cites this paper
• Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold.

  1992cites this paper
• The role of cytokines and their inhibitors in arthritis.

  1992cites this paper
• Oncogene activation in rheumatoid synovium

  1992cites this paper
• Immunotherapy of rheumatic diseases--practice and prospects.

  1991cites this paper
• Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter's disease.

  1991cites this paper
• Antibodies to extracellular matrix proteins in the sera of MRL-lpr mice.

  1991cites this paper
• RHEUMATIC DISEASES Leader Immunotherapy of rheumatoid arthritis

  year unknowncites this paper